Skip to main content
International Journal of Cardiology Hypertension logoLink to International Journal of Cardiology Hypertension
. 2020 Apr 29;5:100028. doi: 10.1016/j.ijchy.2020.100028

Influence of height on blood pressure and hypertension among Bangladeshi adults

Md Tauhidul Islam a,, Md Shahjahan Siraj b, Md Zakiul Hassan b, Mohammad Nayem c, Dipankar Chandra Nag c, Md Aminul Islam c, Rafiqul Islam d, Tapas Mazumder b, Sohel Reza Choudhury e, Ali Tanweer Siddiquee b,f
PMCID: PMC7803027  PMID: 33447757

Abstract

Background

Recent studies have reported that height is inversely associated with blood pressure and hypertension. However, there is lack of comprehensive findings from Bangladesh in this regard.

Objective

The purpose of this study was to explore the association between height and blood pressure in a Bangladeshi population.

Setting

Rural and urban sites from seven divisions of Bangladesh.

Participants

Participants were 7932 males and females (aged ≥35 years) evaluated in the 2011 Bangladesh Demographic Health Survey. Participants (n = 7647) who had complete height, weight, systolic and diastolic blood pressure (SBP and DBP) measurements and non-missing medication history, were included in the analysis.

Methods

Hypertension was defined as an SBP over 140 mmHg or/and a DBP over 90 mmHg, or current use of antihypertensive medication. Difference between SBP and DBP was calculated to get pulse pressure (PP). Multivariate linear and logistic regression models were used.

Results

PP decreased linearly with increasing height among males (−0.11, P < 0.05) and females (−0.19, P < 0.05) after adjusting for age, BMI, living region, type of occupation, wealth index, and highest level of education. SBP decreased linearly with increasing height among only females (−0.14, P < 0.05), after adjusting for age, BMI, living region, type of occupation, wealth index, and highest level of education. No association was found between quartiles of height and prevalence of hypertension.

Conclusions

Height was found to be inversely associated with pulse pressure in both sexes. Studies with longitudinal design are needed to investigate the association between shortness with blood pressure and hypertension.

Keywords: Blood pressure, Body height, Pulse pressure, Mean arterial blood pressure, Systolic blood pressure, Diastolic blood pressure

1. Background

Height being related to the risk of disease and mortality was first reported in late 19th century [1]. Data from the insurance industry in the early 20th century indicated that taller people, on average, lived longer in comparison to shorter people [2]. Height has been linked to a range of health problems, from Alzheimer's and heart disease to several cancers. A recent study investigated the association of adult height with 50 diseases using both epidemiological and genetic approaches, and found that height was associated with 32 diseases and genetically determined height was associated with 12 diseases [3]. However, studies in this arena are mostly focused on cardiovascular disease and only a few studies have examined other illnesses [4].

In 1951 Gertler et al. reported that young men who were at risk for coronary artery disease were about 5 centimetre (cm) shorter than their healthy counterparts [5]. Later, this observation was extended by Paffenbarger and Wing, by studying the risk of developing a fatal stroke among longitudinally followed university students. They found that students who suffered from stroke were 2–3 cm shorter than their classmates [6]. Studies from high income settings have investigated the association between blood pressure and height [[7], [8], [9], [10], [11]], but there is lack of credible evidence from low and middle income countries.

Hypertension is a growing threat to Bangladesh's public health. A nationwide survey from Bangladesh in 2011, reported that the prevalence of hypertension was 26.4% among those aged 35 years and older [12]. Epidemiological studies have established modifiable and unmodifiable risk factors for hypertension, including obesity, high salt intake, alcohol consumption, cigarette smoking, sedentary lifestyles, age and family history [13]. However, there are other factors which needs to be explored. Bangladesh is now passing through a nutritional transition [14] and it is expected that average adult height will continue to increase in this country [15], therefore it is imperative to know whether any relationship between height and blood pressure exists in this population.

A study from Bangladesh in 2014 investigated the association of hypertension and height using the data of Bangladesh Demographic Health Survey, 2011 (BDHS, 2011) [16]. However, the study did not portray the whole picture in this arena. First, the study did not investigate the relationship between blood pressure and height. Secondly, it did not show association of hypertension with height by sex. Bangladeshi males are significantly taller than females, therefore the relationship of hypertension and height should be observed by sex [17]. Most previous studies elsewhere that explored this relationship, analysed this association independently among males and females [[7], [8], [9], [10], [11]]. Considering these limitations of the previous report, we reanalysed the data of BDHS, 2011, to comprehensively examine the association between height, blood pressure and prevalence of hypertension in a middle-age Bangladeshi male and female population separately after the adjustment for potential confounders, and to prove following hypothesis.

1.1. Hypothesis

  • 1.

    There is difference in systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MBP) and pulse pressure (PP) among different height quartiles of Bangladeshi adult males and females.

  • 2.

    SBP and DBP will decrease with higher height quartiles, MBP will increase with higher height quartiles, and PP will be narrowed down with higher height quartiles of Bangladeshi adult males and females.

  • 3.

    There is an inverse linear relationship between height and SBP, DBP and PP; and positive linear relationship between height and MBP of Bangladeshi adult males and females.

  • 4.

    Short height is associated with an increased prevalence of hypertension among Bangladeshi adult males and females.

2. Method

2.1. Study site and design

We used nationally representative data from the 6th Bangladesh Demographic and Health Survey (BDHS), 2011. Secondary analysis of BDHS were done to prove the aforementioned hypothesis. BDHS collect representative sample from all over Bangladesh, covering all the divisions of Bangladesh [18].

2.2. Data source

The Demographic Health Survey (DHS) is a standardised series of surveys routinely conducted in more than 80 developing countries. All data from these surveys are in the public domain of USAID and can be accessed, after registration, from http://www.measuredhs.com. The BDHS is a large, well-established, nationally representative survey based on a multistage cluster random sampling design that provides high-quality information on the health of men, women and children in Bangladesh with an overall response rate of 98%. Unlike other BDHS surveys, the 2011 BDHS specifically aimed to measure blood pressure for males and females aged 35 years and older [18].

From the 2011 Population and Housing Census, a list of enumeration areas (EAs) was prepared for the sampling frame. The EA was considered as the primary sampling unit in both urban and rural areas. In total, 207 clusters in urban areas and 393 clusters in rural areas were selected to get a total of 600 EAs. In the second phase, households were listed in these EAs. With this design, a total of 18,000 residential households were selected and among those, one-third of the households were randomly selected for measurement of blood pressure. All males and females aged 35 years or older in these selected households were approached to measure blood pressure. Details of the survey design, methodologies, sample size calculation, findings, and questionnaires are available elsewhere [18].

2.3. Assessment of blood pressure and hypertension

Blood pressure measurements were taken by making the participants relax and have them seated straight with the arm supported in a fixed position. The WHO-recommended “LIFE SOURCE® UA-767” Plus Blood Pressure Monitor model was used to measure SBP and DBP. Well trained data collectors measured SBP and DBP three times with an interval of ten minutes between measurements for each participant. The average of the last two measures was used to document the final blood pressure value [18]. Besides, participants were asked if they were taking any prescribed anti-hypertensive drugs to lower blood pressure level. PP was calculated as the difference between SBP and DBP, and MBP was calculated as: MBP = [2 × (DBP) + SBP]/3. In the present study, hypertension was defined as an SBP over 140 mmHg or/and a DBP over 90 mmHg, or current use of antihypertensive medication, or participants with a self-reported physician diagnosis of hypertension [13].

2.4. Assessment of height and height quartiles

Height was measured at the participant's home by trained field research staff. Height was measured only once using a standard clinical height scale. Height (to the nearest 0.1 cm) was measured in participants not wearing shoes [18]. The measured height was categorized in sex-specific quartiles (Q). For men, the height quartiles were Q1≤157.4 cm, Q2 157.5–161.6 cm, Q3 161.7–165.9 cm, and Q4 =>166 cm. For women, the corresponding quartiles were Q1≤145.5 cm, Q2 145.6–149.2 cm, Q3 149.3–153.5 cm, and Q4 =>153.6 cm.

2.5. Assessment of covariates

Information on demographic characteristics such as age, living region and occupation were directly collected using the pre-structured questionnaire. Data related to Socioeconomic status (SES) was collected using the Demographic and Health Survey wealth index, which depends on ownership of selected assets to determine relative wealth. The wealth index was developed through principle components analysis. The body mass index (BMI) was calculated by dividing weight in kilograms by height squared in meters [18].

2.6. Statistical analysis

In this study, we excluded participants with either missing value of body height or missing information on systolic blood pressure, diastolic blood pressure and history of medication for blood pressure. In total, 285 participants (3.5% of the total participants) were excluded from this study. The final analyses included 7647 participants (3771 men and 3876 women).

Categorical variables were described in percentage and compared by Chi-square tests. Continuous variables were presented as mean ± standard deviation (SD) for normally distributed data or median (interquartile range) for skewed data, and compared by sex. Difference in SBP, DBP, MBP, PP and other quantitative variables among different height quartiles of Bangladeshi males and females was conducted using ANOVA or Welch ANOVA was done based on the result of the Levene's test of homogeneity of variances. However, for skewed quantitative variables, Kruskal Wallis test was done to assess the difference across the height quartiles. Again, according to the output of Levene's test of homogeneity of variances a Games-Howell test or Tukey post-hoc test was done to assess the difference of SBP, DBP, MBP and PP within different quartiles of height. Trend in SBP, DBP, MBP and PP amongst the quartiles of height were assessed by Jonckheere-Terpstra test. Following this, prevalence of hypertension with confidence interval (CI) was calculated across the height quartiles of Bangladeshi men women, and presence of any trend of prevalence of hypertension within the height quartiles was identified by Mantel-Haenszel linear-by-linear association chi-squared test. We used multivariate linear regression models to compare the association of SBP, PP, MBP and DBP with height. Multivariable logistic regression models were used to estimate ORs and 95% CIs, to measure the association between height quartiles and risk of hypertension after adjustment for potential confounders. Models were fitted using height as categorical variable, based on the quartile distribution of height, and the shortest quartile was defined as the referent group. 266 male participants and 551 female participants were excluded from the analysis during ANOVA or Welch ANOVA, Jonckheere-Terpstra test and multivariate linear regression to remove the effect of anti-hypertensive medication on blood pressure. All statistical analyses were performed by using the SPSS version 20. All statistical tests were two-tailed, and the cut-off of significant level was defined as P < 0.05. All the statistical analyses were weighted according to the guideline of BDHS [18].

2.7. Ethical considerations

The BDHS received ethical approval from Institutional Review Boards (IRB) of the ICF International and Bangladesh Medical Research Council. Prior informed written consent was obtained from each participant [18]. The analysis presented in this study is based on secondary analysis of existing survey data with all identifying information removed, therefore, no ethical approval was sought.

3. Result

3.1. Characteristics of the participants

Table 1 presents the characteristics of the male and female participants and compare variables according to sex. We included 7647 participants in the analysis. Of 7647, 3771 (49.31%) were males. There were significant differences between Bangladeshi males and females in regard to socio-demographic variables including age, education and occupation. No differences were found for region of residence and wealth index. Male participants were more likely to be older, educated and have a manual job. Clinical characteristics of the respondents such as height, weight, BMI, SBP, DBP, MBP, PP, history of taking anti-hypertensive medication, anti-diabetic medication & hypertensive status significantly differed between males and females. Male participants were taller and heavier compared to female participants. On the other hand, female participants had higher BMI, SBP, DBP, MBP & PP. Female participants were also more likely to be hypertensive, on anti-hypertensive medication and on anti-diabetic medication. Characteristics of participants were also observed across height quartiles (Supplemental Table 1) and it was found that most of the characteristics differ significantly across height quartiles, except for history of anti-hypertensive medication and prevalence of diabetes for both males and females, and occupation of female participants.

Table 1.

Characteristics of the participants by sex, Bangladesh demographic health survey, 2011.

Characteristics Male
Female
P-Value
N = 3771 N = 3876
Age, years (Median, IQR)a 50 [41–60] 48 [40–58] <0.001
Age Category
 < 65 years 3054 (81.0) 3270 (84.4) 0.001
 ≥ 65 years 717 (19.0) 606 (15.6)
Living region
 Urban 898 (23.8) 890 (23.0) 0.387
 Rural 2873 (76.2) 2986 (77.0)
Wealth Index, n (%)
 Poorest 744 (19.7) 739 (19.1) 0.818
 Poorer 739 (19.6) 732 (18.9)
 Middle 739 (19.6) 779 (20.1)
 Richer 766 (20.3) 808 (20.8)
 Richest 783 (20.8) 818 (21.1)
Education, n (%)
 No education 1422 (37.7) 3406 (87.9) <0.001
 Primary 1060 (28.1) 345 (8.9)
 Secondary 843 (22.3) 103 (2.7)
 College/Higher 447 (11.9) 23 (0.6)
Occupation, n (%)
 Manual 1847 (49.3) 53 (1.4) <0.001
 Non-manual 1897 (50.7) 3819 (98.6)
Height, cm (Mean ± SD) 161.54 ± 6.54 149.32 ± 6.09 <0.001
Weight, kg (Mean ± SD)b 53.64 ± 10.06 47.66 ± 10.77 <0.001
BMI, kg/m2 (Mean ± SD)b 20.48 ± 3.23 21.24 ± 4.25 <0.001
SBP, mmHg (Mean ± SD) 115.77 ± 18.71 121.14 ± 22.54 <0.001
DBP, mmHg (Mean ± SD) 76.21 ± 11.41 79.54 ± 11.75 0.018
MBP, mmHg (Mean ± SD) 89.39 ± 12.91 93.40 ± 14.25 <0.001
PP (Mean ± SD) 39.55 ± 12.87 41.60 ± 16.21 <0.001
History of medication, n (%)
 For High blood pressure 266 (7.1) 551 (14.2) <0.001
 For High blood glucoseb 122 (3.4) 155 (4.4) 0.023
Prevalence, n (%)
 Hypertension 724 (19.2) 1230 (31.7) <0.001
 Diabetesb 385 (11.1) 422 (12.4) 0.091

Data are mean ± SD for normally distributed data or median (interquartile range) for skewed data, or percentage.

Abbreviation: BMI, body mass index; SD, standard deviation; IQR, Interquartile range; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP; mean arterial blood pressure; PP, pulse pressure.

a

Mann-Whitney U Test was done because of skewed data.

b

Number of missing value for weight = 59, number of missing value for BMI = 62, number of missing value for prevalence of diabetes = 777, number of missing value for history medication for diabetes = 545.

3.2. Mean blood pressure according to height quartiles

Table 2 presents mean SBP, DBP, MBP and PP according to height quartiles. Mean SBP decreased linearly with increasing height among female (P for trend < 0.001). PP showed the same trends as SBP in both male and female (P for trend < 0.001) participants. Among male participants mean DBP and MBP increased linearly with increasing height. (P for trend < 0.001; P for trend 0.017). However, among females MBP decreased linearly with increasing height (P for trend 0.009). Post hoc analyses showed that taller female individuals had lower SBP and PP than those with shorter height (Q2 vs Q1, P < 0.05; Q3 vs Q1, P < 0.05; Q4 vs Q1, P < 0.05). On contrary, taller male individuals had lower PP than those with shorter height (Q2 vs Q1, P < 0.05; Q3 vs Q1, P < 0.05; Q4 vs Q1, P < 0.05). Taller male individuals have higher DBP than those with shorter height (Q3 vs Q1, P < 0.05; Q4 vs Q1, P < 0.05).

Table 2.

Mean SBP, DBP and PP according to height quartiles by sex, Bangladesh demographic health survey, 2011.

Blood pressure Height quartile
P for trend
Q1 Q2 Q3 Q4
Male
 SBP 115.23 ± 19.72 113.51 ± 16.94 114.30 ± 15.52 113.14 ± 15.92 0.970
 DBP 74.60 ± 11.31 74.97 ± 10.95 76.48 ± 10.44μ 76.14 ± 11.24μ <0.001
 MBP 88.14 ± 13.16 87.81 ± 12.05 89.09 ± 11.33 88.47 ± 12.02 0.017
 PP 40.62 ± 13.67 38.53 ± 11.67μ 38.82 ± 10.52μ 37.00 ± 10.40μ <0.001
Female
 SBP 122.57 ± 23.75 118.06 ± 19.42μ 115.94 ± 19.38μ 116.50 ± 18.30μ <0.001
 DBP 78.23 ± 11.77 78.52 ± 10.70 77.47 ± 11.15 79.11 ± 10.71 0.269
 MBP 93.01 ± 14.65 91.69 ± 12.66 90.29 ± 12.98 μ 91.57 ± 12.46 0.009
 PP 44.34 ± 17.20 39.54 ± 13.70μ 38.47 ± 13.33 μ 37.39 ± 12.16 μ <0.001

μP < 0.05 for the comparison with shortest quartile of height, by using Games-Howell test for post hoc analysis.

Abbreviation: Q, Quartile; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure.

3.3. Association between height and blood pressure

Table 3 shows the results from multivariate linear regression analyses, which were used to explore the associations between height and SBP, DBP and PP after adjustment of potential and available covariates. In the analysis, inverse associations were found between height and SBP and PP among male and female participants (model 1) (all P < 0.05). In the fully adjusted model (model 4), a −0.4 mmHg (95% confidence intervals (CI), −0.52, −0.29) linear change in SBP was found in females. For males the relationship was found insignificant in the fully adjusted model (model 4). Each centimetre increase in height was associated with a reduction of 0.11 mmHg for males (P value < 0.05) and 0.19 mmHg for females (P value < 0.05) in PP. No association was found between height and DBP, and MBP after adjusting for potential factors among males and females.

Table 3.

Regression coefficients (95% CIs) of blood pressure components for each centimetre increase in height by sex, Bangladesh demographic health survey, 2011.

SBP
DBP
PP
MBP
Coefficient (95% CI) P value Coefficient (95% CI) P value Coefficient (95% CI) P Value Coefficient (95%CI) P Value
Male
Model 1 −0.09 (−0.18, −0.01) 0.02 0.10 (0.05, 0.16) <0.001 −0.20 (−0.26, −0.14) <0.001 0.22 (−0.13, 0.59) 0.216
Model 2 −0.01 (−0.10, 0.06) 0.666 0.10 (0.04, 0.15) <0.001 −0.12 (−0.18, −0.06) <0.001 0.34 (−0.02, 0.7) 0.069
Model 3 −0.06 (−0.14, 0.02) 0.152 0.06 (0.01, 0.12) 0.01 −0.12 (−0.18, −0.06) <0.001 0.09 (−0.26, 0.44) 0.617
Model 4 −0.08 (−0.17, 0.00) 0.066 0.02 (−0.02, 0.08) 0.15 −0.11 (−0.17, −0.05) <0.001 −0.1 (−0.47, 0.27) 0.6
Female
Model 1 −0.40 (−0.52, −0.29) <0.001 0.03 (−0.25, 0.10) 0.23 −0.44 (−0.52, −0.36) <0.001 −0.11 (−0.18, −0.03) 0.003
Model 2 −0.14 (−0.25, −0.02) 0.017 0.07 (0.004, −0.03) 0.037 −0.21 (−0.29, −0.13) <0.001 −0.01 (−0.09, 0.06) 0.706
Model 3 −0.15 (−0.26, −0.03) 0.01 0.05 (−0.005, 0.12) 0.07 −0.21 (−0.29, −0.13) <0.001 −0.01 (−0.08, 0.06) 0.797
Model 4 −0.14 (−0.26, −0.01) 0.029 0.05 (−0.019, 0.12) 0.158 −0.19 (−0.27, −0.1) <0.001 −0.01 (−0.09, 0.06) 0.757

Model 1: Unadjusted.

Model 2: Adjusted for age.

Model 3: Adjusted for age and BMI.

Model 4: Adjusted for age, BMI, Prevalence of diabetes, Living region, Type of occupation, Wealth index and highest level of education.

Abbreviation: Q, Quartile; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; CI, confidence interval.

3.4. Association between height and hypertension

Table 4 displays the unadjusted, age-adjusted and multivariate-adjusted odds ratios (ORs) and 95% CIs for hypertension according to quartiles of height among males and females. For males, no model provides a significant result. However, for females the unadjusted analysis (model 1) showed that increased height was associated with significantly decreased likelihood of hypertension (the highest vs shortest quartile: OR, 0.75; 95% CI, 0.62, 0.90). Adjustments for potential and available confounders materially changed the significant relationship. Addition to that, prevalence of hypertension according to quartiles of height are shown in Supplemental Fig. 1 and Supplemental Fig. 2 for males and females respectively. Only for females, there was a significant descending linear association between height quartile and prevalence of hypertension.

Table 4.

Unadjusted, age-adjusted and multivariate-adjusted ORs (95% CIs) of hypertension according to height quartiles by sex, Bangladesh demographic health survey, 2011.

Height quartile
Q1 Q2 Q3 Q4
Male
 No of cases 968 966 929 908
 Model 1 1.00 (Ref) 0.88 (0.70, 1.11) 0.97 (0.78, 1.22) 0.97 (0.77, 1.22)
 Model 2 1.00 (Ref) 0.96 (0.76, 1.22) 1.09 (0.87, 1.38) 1.16 (0.91, 1.47)
 Model 3 1.00 (Ref) 0.92 (0.73, 1.17) 0.96 (0.75, 1.22) 1.00 (0.78, 1.28)
 Model 4 1.00 (Ref) 0.90 (0.70, 1.15) 0.84 (0.65, 1.09) 0.88 (0.67, 1.14)
Female
 No of cases 992 949 983 952
 Model 1 1.00 (Ref) 0.73 (0.61, 0.89) 0.72 (0.60, 0.87) 0.75 (0.62, 0.90)
 Model 2 1.00 (Ref) 0.86 (0.71, 1.05) 0.92 (0.76, 1.12) 0.98 (0.81, 1.20)
 Model 3 1.00 (Ref) 0.85 (0.69, 1.04) 0.90 (0.73, 1.10) 0.90 (0.73, 1.11)
 Model 4 1.00 (Ref) 0.91 (0.73, 1.13) 0.92 (0.74, 1.15) 0.93 (0.75, 1.17)

Model 1: Unadjusted.

Model 2: Adjusted for age.

Model 3: Adjusted for age and BMI.

Model 4: Adjusted for age, BMI, Living region, Type of occupation, Wealth index and Highest level of education.

Abbreviation: Q, Quartile.

4. Discussion

In the nationwide survey, we found that increasing height was associated with lower SBP and PP but not with DBP among females, independent of potential confounders. On the other hand, among males association was only found with PP independent of potential confounders. No association was found between height and prevalence of hypertension among the survey population after adjustment of potential confounders, but a descending linear trend of prevalence of hypertension was observed across quartiles from lower to higher for female participants.

Analysis of BDHS 2011 participants, who were not taking antihypertensive medications confirmed that, a significant association is present between adult stature and PP which was also replicated in study from China, USA, Finland, Spain and UK [7,8,11,19,20]. Reports from the Framingham Heart study showed that PP was superior to SBP and DBP to predict Coronary Heart Disease (CHD). High PP is a marker for large artery stiffness, which is the main pulsatile force that contributes to vascular aging from middle age onwards [21]. The underlying mechanism is that due to large artery stiffness, SBP rises and DBP falls, resulting an increase in PP [22]. Though our analysis did not show the relationship between height and CHD, based on the findings of Framingham heart study we could argue that Bangladeshi people with shorter height and with high PP might be at risk of CHD.

Evidence on biological plausibility of high PP and SBP and short stature is scarce, however, a 2016 study from China with similar evidence suggested that the dynamic effect of the arterial tree is reflected on the relationship between height and hypertension. The reflected waves reach at the central aorta at a normal pulse wave velocity in the late systole and/or early diastole. Individuals with short stature have short length of arterial tree, therefore in short persons, the reflected waves have greater possibility to reach the central aorta earlier and augment central pressure and PP in the late systole, when compared to a taller person [7]. Besides, the most common explanation is that impaired foetal and infancy development due to malnutrition might influence non-communicable diseases such as hypertension and diabetes in later life, which is also known as “thrifty phenotype hypothesis” [23,24]. Studies argued that the individuals who were raised in low socio-economic conditions during childhood were associated with increased SBP and/or DBP in adulthood [25] or to have adverse cardiovascular risk factors during adulthood [[26], [27], [28], [29]]. Stefan et al. provided additional evidence and explained the relationship between height and cardiometabolic risk [15]. This study reported that taller persons have good pulmonary function; lower heart rates and increased parasympathetic activity; larger coronary vessel diameter; lower blood cholesterol and triglyceride concentration; all of which reduce the risk of CVD among taller people in comparison to shorter people [15].

Our analysis also highlighted a divergent association between height and SBP among female only which is concurrent with the findings from Brazilian studies [9,30]. Possible biological plausibility of the divergent association between height and SBP among females is that the calibre of coronary arteries in females is smaller than males which might increase the risk of having higher SBP among females [15]. However, studies from other part of the world found the divergent association between height and SBP in both males and females, but showed that the dose dependent relationship is much stronger in females compare to males [7,8,19,31].

Like the study in China, our results did not find a conclusive relationship between shorter height and increased prevalence of hypertension among males and females. However, this result might have been different if analyses could be adjusted by the major contributors of hypertension, such as smoking, unhealthy diet, and physical inactivity. Height might not be directly related to smoking, unhealthy diet, and physical inactivity, but it is directly related with socio-economic status of the participants. People with lower socioeconomic status tend to be shorter than those with higher socioeconomic status [32]. People with lower socio-economic status are also more prone to unhealthy lifestyle such as smoking, unhealthy diet and physical inactivity [33]. Therefore, our analysis could be mediated by smoking, unhealthy diet, and physical inactivity. It should also be noted that the average height of Bangladeshi people might already be relatively low, thus limiting our ability to see the difference in prevalence of hypertension across different quartiles of height.

Average heights of men and women in USA are 177 cm and 163 cm respectively [8], whereas the average height of Bangladeshi men and women are 161 cm and 149 cm respectively (Table 1). Average height of Chinese male and female are almost 5 cm higher than Bangladeshi males and females [7]. Therefore, it might have been easier for studies from USA and China to find the significant differences in prevalence of hypertension across different quartiles of height. Moreover, an analysis from the University of Tuebingen showed that the average height in developed countries increased substantially in the last 140 years, over the last 140 years the average height of Dutch men increased by 17.4 cm, whereas in the last 140 years, average height of Bangladeshi men increased by only 0.6 cm [34].

Another major limitation of the study is an absence of childhood nutrition data, because the underlying association between height and hypertension could be mediated by nutrition during childhood. Height is not only an imperative marker of malnutrition in childhood, but also a marker of mothers’ nutrition during pregnancy [35]. Some studies have already reported that malnutrition during critical periods in early life might increase the risk of developing hypertension [36]. Due to the lack of childhood nutrition data of the respondents, it was not possible to explore whether height itself or malnutrition had an effect on hypertension in adulthood. Another major limitation was the use of cross-sectional data to establish the causal association between height and hypertension. One of the strengths of the study was that it involved all 7 divisions of Bangladesh which enhanced the generalizability of the result. In addition, BDHS uses standard questionnaires and medical measurements to collect quality assured data on demographics, socioeconomic status, and medical history of diseases which enhanced the reliability of our results [18].

5. Conclusion

Although this study did not find a significant relationship between height quartiles and prevalence of hypertension, height was found to be inversely associated with pulse pressure in both sexes. This evidence is important since it could provide a possible explanation for short stature being an independent risk factor for cardiovascular disease in middle aged older Bangladeshi adults. Future investigations preferably with longitudinal design is needed to further clarify our understanding of the potential association between height and the risk of developing hypertension and possibly CVDs.

Funding

The research received no specific grant from any funding agencies in the public, commercial or non-for-profit sectors.

Availability of data and material

Data may be made available upon request to the ICF International, Maryland, USA.

Authors’ information

No additional information to disclose.

Consent for publication

Not applicable for this study.

CRediT authorship contribution statement

Md. Tauhidul Islam: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing - original draft, Writing - review & editing. Md. Shahjahan Siraj: Data curation, Formal analysis, Writing - review & editing. Md. Zakiul Hassan: Writing - review & editing. Mohammad Nayem: Writing - review & editing. Dipankar Chandra Nag: Writing - review & editing. Md. Aminul Islam: Writing - review & editing. Rafiqul Islam: Writing - review & editing. Tapas Mazumder: Writing - review & editing. Sohel Reza Choudhury: Writing - review & editing. Ali Tanweer Siddiquee: Writing - review & editing.

Declaration of Competing Interest

The authors declare that they have no competing interests.

Acknowledgement

We are thankful to the ICF International, Rockville, Maryland, USAfor giving us the permission to use the data. The author also would like to acknowledge the Bangladesh Demographic Health and Health Survey (BDHS) team and all the participants during 2011 survey.

Footnotes

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.ijchy.2020.100028.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Multimedia component 1
mmc1.docx (74.4KB, docx)
Multimedia component 2
mmc2.docx (79.7KB, docx)
Multimedia component 3
mmc3.docx (22.3KB, docx)

References

  • 1.British Association for the Advancement of Science . COMMITTEE; London: 1883. THE FINAL REPORT OF THE ANTHROPOMETRIC. [Google Scholar]
  • 2.Dublin L., Lotka A., Spiegelman M. 1949. Length of Life: a Study of the Life Table. New York. [Google Scholar]
  • 3.Lai F.Y., Nath M., Hamby S.E., Thompson J.R., Nelson C.P., Samani N.J. Adult height and risk of 50 diseases: a combined epidemiological and genetic analysis. BMC Med. 2018;16 doi: 10.1186/s12916-018-1175-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Smith G.D., Hart C., Upton M., Hole D., Gillis C., Watt G. Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J. Epidemiol. Community Health. 2000;54:97–103. doi: 10.1136/jech.54.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gertler M.M., Garn S.M., White P.D. Young candidates for coronary heart disease. J. Am. Med. Assoc. 1951;147:621–625. doi: 10.1001/jama.1951.03670240005002. [DOI] [PubMed] [Google Scholar]
  • 6.Paffenbarger R.S., Jr., Wing A.L. Characteristics in youth predisposing to fatal stroke in later years. Lancet. 1967;289:753–754. doi: 10.1016/s0140-6736(67)91367-0. [DOI] [PubMed] [Google Scholar]
  • 7.Song L., Shen L., Li H., Liu B., Zheng X., Liang Y. Height and prevalence of hypertension in a middle-aged and older Chinese population. Sci. Rep. 2016;6:39480. doi: 10.1038/srep39480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bourgeois B., Watts K., Thomas D.M., Carmichael O., Hu F.B., Heo M. Associations between height and blood pressure in the United States population. Med (United States) 2017:96. doi: 10.1097/MD.0000000000009233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Sichieri R., Siqueira K.S., Pereira R.A., Ascherio A. Short stature and hypertension in the city of Rio de Janeiro, Brazil. Publ. Health Nutr. 2000;3:77–82. doi: 10.1017/s1368980000000094. [DOI] [PubMed] [Google Scholar]
  • 10.Olatunbosun S.T., Bella A.F. Relationship between height, glucose intolerance, and hypertension in an urban African black adult population: a case for the" thrifty phenotype" hypothesis? J. Natl. Med. Assoc. 2000;92:265. [PMC free article] [PubMed] [Google Scholar]
  • 11.Korhonen P.E., Kautiainen H., Eriksson J.G. The shorter the person, the higher the blood pressure: a birth cohort study. J. Hypertens. 2017;35(6):1170–1177. doi: 10.1097/HJH.0000000000001300. [DOI] [PubMed] [Google Scholar]
  • 12.Chowdhury M.A.B., Uddin M.J., Haque M.R., Ibrahimou B. Hypertension among adults in Bangladesh: evidence from a national cross-sectional survey. BMC Cardiovasc. Disord. 2016;16:22. doi: 10.1186/s12872-016-0197-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo J.L., Jr. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289:2560–2571. doi: 10.1001/jama.289.19.2560. [DOI] [PubMed] [Google Scholar]
  • 14.Amuna P., Zotor F.B. Epidemiological and nutrition transition in developing countries: impact on human health and development. Proc. Nutr. Soc. 2008;67(1):82–90. doi: 10.1017/S0029665108006058. [DOI] [PubMed] [Google Scholar]
  • 15.Stefan N., Häring H.-U., Hu F.B., Schulze M.B. Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications. Lancet Diabetes Endocrinol. 2016;4:457–467. doi: 10.1016/S2213-8587(15)00474-X. [DOI] [PubMed] [Google Scholar]
  • 16.Hoque M.E., Khokan M.R., Bari W. Impact of stature on non-communicable diseases: evidence based on Bangladesh Demographic and Health Survey, 2011 data. BMC Publ. Health. 2014;14:1007. doi: 10.1186/1471-2458-14-1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sultana T., Karim M.N., Ahmed T., Hossain M.I. Assessment of under nutrition of Bangladeshi adults using anthropometry: can body mass index be replaced by mid-upper-arm-circumference? PloS One. 2015;10 doi: 10.1371/journal.pone.0121456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.NIPORT, Mitra and Associates, ICF International . Natl Inst Popul Res Train 2013; 2011. Bangladesh Demographic and Health Survey. [Google Scholar]
  • 19.Langenberg C., Hardy R., Breeze E., Kuh D., Wadsworth M.E.J. Influence of short stature on the change in pulse pressure, systolic and diastolic blood pressure from age 36 to 53 years: an analysis using multilevel models. Int. J. Epidemiol. 2005;34:905–913. doi: 10.1093/ije/dyi071. [DOI] [PubMed] [Google Scholar]
  • 20.Regidor E., Banegas J.R., Gutiérrez-Fisac J.L., Domínguez V., Rodríguez-Artalejo F. Influence of childhood socioeconomic circumstances, height, and obesity on pulse pressure and systolic and diastolic blood pressure in older people. J. Hum. Hypertens. 2006;20(1):73–82. doi: 10.1038/sj.jhh.1001925. [DOI] [PubMed] [Google Scholar]
  • 21.Franklin S.S., Wong N.D. Pulse pressure how valuable as a diagnostic and therapeutic tool? J. Am. Coll. Cardiol. 2016;67:404–406. doi: 10.1016/j.jacc.2015.11.022. [DOI] [PubMed] [Google Scholar]
  • 22.Levy M.N., Pappano A.J., Berne R.M., others . vol. 146. Mosby Elsevier; Philadelphia: 2007. (Cardiovascular Physiology). [Google Scholar]
  • 23.Hales C.N., Barker D.J.P. The thrifty phenotype hypothesis: type 2 diabetes. Br. Med. Bull. 2001;60:5–20. doi: 10.1093/bmb/60.1.5. [DOI] [PubMed] [Google Scholar]
  • 24.Neel J.V. Diabetes mellitus: a “thrifty” genotype rendered detrimental by “progress”? Am. J. Hum. Genet. 1962;14:353. [PMC free article] [PubMed] [Google Scholar]
  • 25.Conen D., Glynn R.J., Ridker P.M., Buring J.E., Albert M.A. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur. Heart J. 2009;30:1378–1384. doi: 10.1093/eurheartj/ehp072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wadsworth M.E.J., Hardy R.J., Paul A.A., Marshall S.F., Cole T.J. Leg and trunk length at 43 years in relation to childhood health, diet and family circumstances; evidence from the 1946 national birth cohort. Int. J. Epidemiol. 2002;31:383–390. [PubMed] [Google Scholar]
  • 27.Gunnell D., Whitley E., Upton M.N., McConnachie A., Smith G.D., Watt G.C.M. Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study. J. Epidemiol. Community Health. 2003;57:141–146. doi: 10.1136/jech.57.2.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wamala S.P., Lynch J., Kaplan G.A. Women's exposure to early and later life socioeconomic disadvantage and coronary heart disease risk: the Stockholm Female Coronary Risk Study. Int. J. Epidemiol. 2001;30:275–284. doi: 10.1093/ije/30.2.275. [DOI] [PubMed] [Google Scholar]
  • 29.Mamidi R.S., Kulkarni B., Singh A. Secular trends in height in different states of India in relation to socioeconomic characteristics and dietary intakes. Food Nutr. Bull. 2011;32:23–34. doi: 10.1177/156482651103200103. [DOI] [PubMed] [Google Scholar]
  • 30.Florêncio T.T., Ferreira H.S., Cavalcante J.C., Sawaya A.L. Short stature, obesity and arterial hypertension in a very low income population in North-eastern Brazil. Nutr. Metabol. Cardiovasc. Dis. 2004;14:26–33. doi: 10.1016/s0939-4753(04)80044-9. [DOI] [PubMed] [Google Scholar]
  • 31.Merad-boudia H.N., Dali-Sahi M., Kachekouche Y., Dennouni-Medjati N. Hematologic disorders during essential hypertension. Diabetes Metab Syndr Clin Res Rev. 2019;13(2):1575–1579. doi: 10.1016/J.DSX.2019.03.011. [DOI] [PubMed] [Google Scholar]
  • 32.Floud R., Fogel R.W., Harris B., Hong S.C. The changing body: health, nutrition, and human development in the western world since 1700. 2011. [DOI] [PMC free article] [PubMed]
  • 33.Hosseinpoor A.R., Bergen N., Kunst A., Harper S., Guthold R., Rekve D. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: results from the World Health Survey. BMC Publ. Health. 2012;12(912) doi: 10.1186/1471-2458-12-912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Roser M. 2019. Human height 2019.https://ourworldindata.org/human-height [Google Scholar]
  • 35.Perkins J.M., Subramanian S.V., Smith G.D., Özaltin E. Adult height, nutrition, and population health. Nutr. Rev. 2016;74:149–165. doi: 10.1093/nutrit/nuv105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Järvelin M.R., Sovio U., King V., Lauren L., Xu B., McCarthy M.I. Early life factors and blood pressure at age 31 years in the 1966 Northern Finland birth cohort. Hypertension. 2004;44:838–846. doi: 10.1161/01.HYP.0000148304.33869.ee. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (74.4KB, docx)
Multimedia component 2
mmc2.docx (79.7KB, docx)
Multimedia component 3
mmc3.docx (22.3KB, docx)

Data Availability Statement

Data may be made available upon request to the ICF International, Maryland, USA.


Articles from International Journal of Cardiology Hypertension are provided here courtesy of Elsevier

RESOURCES